Respiratory distress syndrome
[대역어] 호흡곤란 증후군
[용어속성] Disease
[용어속성] Disease
Post-Covid-19 Cholangiopathy-A New Indication for Liver Transplantation: A Case Report
PostCovid-19 담관병증-간 이식의 새로운 적응증: 증례 보고
Case Reports
[키워드] acute respiratory distress
acute respiratory distress syndrome
Case report
Cholangitis
coronavirus disease
Coronavirus disease 2019
COVID-19
Critically ill
Critically ill patient
critically ill patients
described
General population
indication
Injury
knowledge
Liver disease
Liver injury
liver test
Liver transplantation
manifestation
New
outcome
Patient
report
reported
respiratory distress
Respiratory distress syndrome
sclerosing cholangitis
suggested
syndrome
variant
[DOI] 10.1016/j.transproceed.2021.03.007 PMC 바로가기 [Article Type] Case Reports
[DOI] 10.1016/j.transproceed.2021.03.007 PMC 바로가기 [Article Type] Case Reports
Continuous renal replacement therapy with the addition of CytoSorb cartridge in critically ill patients with COVID-19 plus acute kidney injury: A case-series
COVID-19와 급성 신장 손상이 있는 중환자에서 CytoSorb 카트리지를 추가하여 지속적인 신대체 요법: 사례 시리즈
Article
[키워드] 95% CI
acute kidney
Acute kidney injury
acute respiratory distress
acute respiratory distress syndrome
addition
Admission
AKI
Analysis
analyzed
Antibiotics
anticoagulation
APACHE
ARDS
arterial pressure
assessment
body mass
body mass index
C-reactive protein
cartridge
chronic
Concentration
Continuous
Continuous renal replacement therapy
continuous renal replacement therapy with cytosorb
COVID-19
COVID-19 patient
Critically ill
critically ill COVID-19 patients
Critically ill patient
CRRT
CRS
cutoff point
Cytokine release syndrome
Cytosorb
D-dimers
Duration
enrolled
ferritin
function
Hospital mortality
Hydrocortisone
hyperinflammation
ICU
ICU admission
in-hospital mortality
inflammatory biomarkers
intensive care
interferon
interferon beta
Interferon beta-1b
interleukin
interleukin-6
Lactate
lactate dehydrogenase
life-threatening
lymphocyte
Lymphocyte count
lymphocyte counts
male
mechanical ventilation
Mortality
nonsurvivors
organ function
oxygen
Oxygenation
PaO
Patient
Physiology
predicted
prone positioning
Prophylactic
prophylactic anticoagulation
provided
Pulmonary emboli
renal replacement therapy
replacement therapy
respiratory distress
Respiratory distress syndrome
retrospective
ribavirin
Safe
Sepsis
Septic shock
Shock
Side effect
SOFA
SOFA scores
survivor
Survivors
syndrome
therapy
Thromboembolism
Ventilation
were recorded
with COVID-19
[DOI] 10.1111/aor.13864 PMC 바로가기 [Article Type] Article
[DOI] 10.1111/aor.13864 PMC 바로가기 [Article Type] Article
The value of anal swab RT-PCR for COVID-19 diagnosis in adult Indonesian patients
성인 인도네시아 환자에서 COVID-19 진단을 위한 항문 면봉 RT-PCR의 가치
Observational Study
[키워드] acute respiratory distress
acute respiratory distress syndrome
Anal
anal swab
analysed
Analysis
anorexia
Chain Reaction
collected
conducted
COVID-19
COVID-19 diagnosis
COVID-19 patients
diagnostic
diagnostic investigation
diagnostic test
diagnostic virology.
Gastrointestinal symptom
gastrointestinal symptoms
hospitalised
Hospitalised patients
Indonesia
Laboratory
mild cases
Mitra
nasopharyngeal
Nasopharyngeal swab
nasopharyngeal swab PCR
nausea
Negative predictive value
Patient
PCR test
polymerase chain
polymerase chain reaction
positive
positive result
Predictive value
remained
respiratory distress
Respiratory distress syndrome
reverse transcription
reverse transcription polymerase chain reaction
RT-PCR
SARS-CoV-2 antigen
SARS-CoV-2 RNA detection
sensitivity
Sensitivity and specificity
specificity
specimen
subgroup of patient
subject
Swab
syndrome
[DOI] 10.1136/bmjgast-2020-000590 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1136/bmjgast-2020-000590 PMC 바로가기 [Article Type] Observational Study
Krebs von den Lungen 6 (KL-6) as a marker for disease severity and persistent radiological abnormalities following COVID-19 infection at 12 weeks
Krebs von den Lungen 6(KL-6)은 12주에 COVID-19 감염 후 질병 중증도 및 지속적인 방사선 이상에 대한 마커입니다.
Observational Study
[키워드] abnormal CT scans
abnormality
absence
acute COVID-19
acute infection
acute respiratory distress
acute respiratory distress syndrome
Admission
age
ARDS
association
Asymptomatic
baseline
breathlessness
cell injury
clinical manifestation
clinical manifestations
Clinical severity
Cohort
Complication
convalescent
correlation
COVID-19 infection
CT scan
CXR
deconditioning
determine
disease severity
Dyspnoea
epithelial cell
fibrosis
finding
Follow up appointment
glycoprotein
help
hospital
include
Infection
initial
Injury
Lung fibrosis
male
marker
median
medium
mucin
no significant difference
observational study
on admission
oxygen
Patient
patients
persistence
presence or absence
proportion
Prospective
pulmonary epithelial cell
radiological abnormalities
radiological abnormality
Research question
respiratory distress
Respiratory distress syndrome
Result
severity
significant difference
significantly higher
syndrome
with COVID-19
[DOI] 10.1371/journal.pone.0249607 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1371/journal.pone.0249607 PMC 바로가기 [Article Type] Observational Study
Increased Serum Levels of Soluble TNF-α Receptor Is Associated With ICU Mortality in COVID-19 Patients
가용성 TNF-α 수용체의 증가된 혈청 수준은 COVID-19 환자의 ICU 사망률과 관련이 있습니다
Immunology
[키워드] acute respiratory distress
acute respiratory distress syndrome
acute respiratory syndrome
acute respiratory syndrome coronavirus
Admission
age
ARDS
Biomarker
cause
Concentration
coronavirus
coronavirus disease
Coronavirus disease 2019
correlated
COVID-19
COVID-19 disease
cytokine
Cytokine storm
death
determinant
determinants
disease
disease severity
ELISA
ESR
Future
greater
healthy control
healthy subjects
ICU
ICU patient
ICU Patients
Increased
intensive care
intensive care unit
Iran
laboratory-confirmed
Laboratory-confirmed COVID-19
Level
Mild
Mortality
non-ICU
non-ICU patient
non-ICU patients
objective
Older
outcome
Patient
positively correlated
receptor
recruited
respiratory
respiratory distress
Respiratory distress syndrome
Result
SARS-CoV-2
serum
Serum level
serum levels
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
severe COVID-19
severe COVID-19 disease
severe COVID-19 patient
severe COVID-19 patients
severe disease
significantly higher
soluble TNF-α
subject
syndrome
Tehran
the healthy
TNF-α
TNF-α
Ventilation
[DOI] 10.3389/fimmu.2021.592727 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2021.592727 PMC 바로가기 [Article Type] Immunology
Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study
Observational Study
[키워드] 95% CI
acute respiratory distress
Adequate
Admission
adult COVID-19 patient
affected
analysed
Artificial respiration
Care
Characteristics
clinical
Clinical course
Cohort
concentrations
Coronavirus disease 2019 (COVID-19)
COVID-19
COVID-19 nucleic acid testing
described
disease trajectories
duration of hospitalisation
duration of symptom
enrolled
European
First wave
Healthcare systems
hospitalised
hospitalised COVID-19 patient
hypertension
identify
IMV
Invasive mechanical ventilation
IQR
knowledge
less
management
mechanical ventilation
Patient
patients
per day
prospective observational study
Prospective Study
required
resource
Respiratory distress syndrome
Result
risk factor
SARS-CoV-2
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
severe disease
short duration
strained
supplementary material
Symptom
Symptom assessment
syndrome
the SARS-CoV-2
Viral concentration
viral kinetics
Viral load
Virological
[DOI] 10.1007/s15010-021-01594-w PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1007/s15010-021-01594-w PMC 바로가기 [Article Type] Observational Study
A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial
SARS-CoV-2 유발 급성 호흡곤란 증후군에 대한 정맥내 혈장 정제 알파-1 항트립신의 무작위 이중 맹검 위약 대조 파일럿 시험: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] 24 hours
active malignancy
acute kidney
Acute kidney injury
acute respiratory distress syndrome
addition
Administered
administration
adverse event
adverse events
AEs
age
Alpha
alpha-1 antitrypsin
Amendment
Anti-viral
Antibiotics
anticipated
antitrypsin
antivirals
approval
approved
ARDS
ARMS
authority
bacterial pneumonia
baseline
Berlin criteria
blinded to treatment
Blinding
BMI
body weight
Cancer
changes in
Child-Pugh score
chloride
Chronic kidney disease
chronic liver disease
circulating
class
clinical
Clinical outcome
clinical trial
Combination
commenced
Committee
comparator
Complete
conducted
Consent
Controlled trial
correction
COVID-19
Culture
cytokine level
cytokine levels
Data collection
defined
determine
Diagnosis
diagnosis of ARDS
dialysis
dissemination
DNAR
double-blind
Echocardiogram
Effect
Effectiveness
elapsed
element
ELISA
enrolled
EudraCT
excluded
exclusion
exclusion criteria
facilitate
Follow-up
followed by
for inclusion
group
Health Products regulatory Authority
hospital
Hospital admission
hypertension
ICU
IgA deficiency
IL-10
IL-1β
IL-6
IL-8
incidence
inclusion criteria
individual
information
intensive care unit
intensive care units
interim analysis
interleukin
interleukin-10
interleukin-1β
interleukin-6
interleukin-8
interpreter
Intervention
intravenous
intravenous infusion
intravenously
invasive
investigational medicinal product
investigator
Ireland
Kidney disease
Laboratory
laboratory-confirmed
life
Local
maintain
major trauma
malignancy
mandatory
marker
mechanical ventilation
Microscopy
moderate
moderate to severe
Mortality
Non-invasive
non-invasive mechanical ventilation
non-invasive ventilation
number
objective
occur
Organ failure
outcome
outcome measure
PaO
participant
Patient
patient recruitment
patients with moderate
PCR-confirmed
Phase 2
physician
Placebo
placebo-controlled
plasma
plasma analysis
plasma concentration
plasma concentrations
pregnant
preparation
product
protocol
provided
Pulmonary embolism
pulmonary hypertension
purified
Radiographic
randomisation
randomisation list
randomised
randomised controlled trial
rationale
readmission
REC
receiving
receptor
recruited
recruitment
reduce
Regulatory
removal
renal
renal replacement therapy
replacement therapy
reported
required
Research
Research Ethics
Research Ethics Committee
research nurse
research nurses
respiratory
respiratory distress
Respiratory distress syndrome
resulting
Resuscitation
SAE
SAEs
Sample size
SARS-CoV-2
secondary
secondary bacterial pneumonia
Secondary objective
Secondary objectives
Secondary outcomes
secretion
Sequential Organ Failure Assessment
Serious Adverse Event
Serious Adverse Events
severe ARDS
Shock
single dose
skin cancer
Sodium chloride
SOFA
Standard
statistician
stratified
study participation
Study protocol
subject
submitted
supplementary material
Support
sustained
TNF
TNF-α
Tolerability
trauma
Treatment
treatment allocation
Trial
trial protocol
Trial registration
vasopressors
ventilator
verbal
Version
Volume
website
WHO
Withdrawal
writing
[DOI] 10.1186/s13063-021-05254-0 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-021-05254-0 PMC 바로가기 [Article Type] Letter
Comparison of host endothelial, epithelial and inflammatory response in ICU patients with and without COVID-19: a prospective observational cohort study
COVID-19 유무에 관계없이 ICU 환자의 숙주 내피, 상피 및 염증 반응의 비교: 전향적 관찰 코호트 연구
Observational Study
[키워드] Acute kidney injury
acute phase
acute respiratory distress
acute respiratory distress syndrome
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
amyloid A
angiopoietin
biological pathway
Biomarker
Blood
both groups
cause
cell injury
characteristic
collected
Concentration
coronavirus
COVID-19
Critical
Critical illness
Critically ill
demographics
diagnose
diagnoses
end products
endothelial
Endothelial dysfunction
enrolled
epithelial
epithelial cell
evaluate
followed by
groups
Host
host response
ICU admission
ICU patient
ICU Patients
in both group
in-hospital mortality
Inflammation
Inflammatory biomarker
Inflammatory response
interleukin
interleukin 6
Invasive mechanical ventilation
involved
marker
Mortality
Necrosis
Non-COVID-19
non-COVID-19 patient
Non-COVID-19 patients
not different
Pathways
Patient
plasma biomarker
Pneumonia
positive
proportion
prospective observational cohort
Protein
receptor
respiratory
respiratory distress
Respiratory distress syndrome
Respiratory failure
Result
resulting
SAA
SARS-CoV-2
SARS-COV-2 infection
Sepsis
serum amyloid
severe acute respiratory syndrome Coronavirus
severe COVID-19
significantly higher
significantly lower
sTNFR
study enrollment
supplementary material
syndrome
target
targets
Therapeutics
Tumor
tumor necrosis
tumor necrosis factor
Viral
viral infection
while
[DOI] 10.1186/s13054-021-03547-z PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1186/s13054-021-03547-z PMC 바로가기 [Article Type] Observational Study
SARS-CoV-2 Serum Neutralization Assay: A Traditional Tool for a Brand-New Virus
SARS-CoV-2 혈청 중화 분석: 새로운 바이러스에 대한 전통적인 도구
Article
[키워드] acute respiratory distress
acute respiratory distress syndrome
Algorithm
Analysis
anti-SARS-CoV-2 IgG
antibody
Antibody-mediated immunity
automated
characteristic
collected
convalescent COVID-19 patient
convalescent plasma
correlation
COVID-19 patients
cutoff value
determine
develop
Donor
donors
FIVE
gold
gold standard
IgA
IgM
Immunity
individual
ineligible
Laboratory
large sample
live SARS-CoV-2
Microneutralization test
MNT
MONITOR
NAb
NAb titer
NAbs
Neutralizing antibodies
neutralizing antibody
Patient
plasma
presenting
protective immunity
receiver
receiver operating characteristic
respiratory distress
Respiratory distress syndrome
ROC
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 NAb
serology
Serum Neutralization
serum sample
serum samples
SmaRT
symptom onset
syndrome
tested
titers
Traditional
vaccinated individuals
Viral
Viral antigen
viral antigens
were measured
[DOI] 10.3390/v13040655 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/v13040655 PMC 바로가기 [Article Type] Article